|
bioMérieux, specialized in the in vitro diagnostics sector, designs, develops, produces and markets diagnosis systems (reagents, instruments and software) for medical or industrial applications.
bioMérieux is listed on the NYSE Euronext Paris market (Code: BIM – Code ISIN: FR0010096479).
The bioMérieux Investor Relations section provides financial information about the company for investors, individual shareholders and the whole finance community.
Here you will find:
|